Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for April 2006
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

UK pharma industry unites to take the Code to customers
Industry acts on call for greater regulation..(more)

 Companies share secrets to reduce unforeseen phase I problems
Nine out of ten compounds fail in phase 1 trials..(more)

 Osteoporosis drug Evista can prevent breast cancer
Evista shows significant advantages over older treatment..(more)

 Biotech buy helps Pfizer expand neuroscience research
Treatment for neurological conditions high priority for Pfizer..(more)

 Make small changes to 'add years to your life' urges government
Life expectancy could increase by 12 years..(more)

 GSK unveils first of new virtual pipeline drug discovery alliances
"Fleet of foot' operations may speed up breakthrough process..(more)

 Lipitor remains England's biggest seller
Sales grew nearly 4 million pounds..(more)

 Pfizer vows to fight 'perverse and short-sighted decision' on Exubera
World's first inhaled insulin rejected..(more)

 New marker points in the right direction for GSK heart drug
Progress in treatment of heart disease..(more)

 Herceptin court victory for breast cancer patient
"I've got my life back," says Rogers..(more)

 Industry warns of worrying signs from NHS drugs bill
NHS spending less in relation to budget..(more)

 Remicade to treat ulcerative colitis in UK
UK's first biologic treatment for disease..(more)

 Restructure will cut costs and improve NHS services, says Hewitt
England's PCT trusts adopt greater strategic role..(more)

 Patients fight NICE over cancer fatigue drugs
NICE says treatment is ineffective ..(more)

 Wyeth to collaborate with Scottish universities on biomarkers
Translational medicine aims to bridge research gap..(more)

 Fears for UK clinical trials as antibody inquiry proceeds
UK's research base faces criticism..(more)

 New GP surgery openings 'quicker than Tesco'
All-in-one health centres on the rise..(more)

 NHS lurches into new financial year with old debts and new challenges
What exactly does April signify for the NHS?..(more)

 Lyrica to challenge antidepressants with new anxiety disorder approval
Positive results suggest drug is fast acting..(more)

 Nearly half of doctors unaware of industry Code of Practice
New survey reveals suprising news..(more)

 Taxotere approved for stomach cancer in US
First advance in treatment in over a decade..(more)

 Novartis targets China with hepatitis drug
Nearly 1 in 10 of the Chinese population affected..(more)

 Novartis to develop Servier's antidepressant for US
Drug currently in phase III clinical trials..(more)

 Novartis launch innovative leukaemia awareness campaign
First of a new generation of medicines to target cancer..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.